Your browser doesn't support javascript.
loading
Drastic Response of Rechallenge of Nivolumab in a Patient with NSCLC Who Progressed on the First Nivolumab Treatment.
Hirano, Satoshi; Hayama, Nami; Tabeta, Hiroshi; Kuroki, Tsuguko; Shiraishi, Yuka; Fujita, Tetsuo; Amano, Hiroyuki; Nakamura, Makoto; Shimizu, Shinichiro; Nakamura, Sukeyuki.
Afiliación
  • Hirano S; Department of Medical Oncology, Funabashi Municipal Medical Center, Chiba, Japan. Electronic address: shirano@mmc.funabashi.chiba.jp.
  • Hayama N; Department of Respiratory Medicine, Funabashi Municipal Medical Center, Chiba, Japan.
  • Tabeta H; Department of Palliative Care Medicine, Funabashi Municipal Medical Center, Chiba, Japan.
  • Kuroki T; Department of Respiratory Medicine, Funabashi Municipal Medical Center, Chiba, Japan.
  • Shiraishi Y; Department of Respiratory Medicine, Funabashi Municipal Medical Center, Chiba, Japan.
  • Fujita T; Department of Respiratory Medicine, Funabashi Municipal Medical Center, Chiba, Japan.
  • Amano H; Department of Respiratory Medicine, Funabashi Municipal Medical Center, Chiba, Japan.
  • Nakamura M; Department of Respiratory Medicine, Funabashi Municipal Medical Center, Chiba, Japan.
  • Shimizu S; Department of Pathology, Funabashi Municipal Medical Center, Chiba, Japan.
  • Nakamura S; Department of Respiratory Medicine, Funabashi Municipal Medical Center, Chiba, Japan.
J Thorac Oncol ; 15(1): e20-e22, 2020 01.
Article en En | MEDLINE | ID: mdl-31864556

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2020 Tipo del documento: Article